APA (7th ed.) Citation

Arezoumand, K. S., Akhtar, G. B., Kadar Shahib, A., Jarmasz, J. S., Roberts, C., Mehrabadi, A. R., . . . Rastegar, M. (2026). Metformin Treatment Shows Beneficial Effects on RTT-Associated Phenotypical Deficits in Mecp2 T158M Male Mice. Pharmaceuticals (14248247), 19(4), 621. https://doi.org/10.3390/ph19040621

Chicago Style (17th ed.) Citation

Arezoumand, Khatereh Saei, Ghanan Bin Akhtar, Ashraf Kadar Shahib, Jessica S. Jarmasz, Chris-Tiann Roberts, Abbas Rezaeian Mehrabadi, Carl O. Olson, and Mojgan Rastegar. "Metformin Treatment Shows Beneficial Effects on RTT-Associated Phenotypical Deficits in Mecp2 T158M Male Mice." Pharmaceuticals (14248247) 19, no. 4 (2026): 621. https://doi.org/10.3390/ph19040621.

MLA (9th ed.) Citation

Arezoumand, Khatereh Saei, et al. "Metformin Treatment Shows Beneficial Effects on RTT-Associated Phenotypical Deficits in Mecp2 T158M Male Mice." Pharmaceuticals (14248247), vol. 19, no. 4, 2026, p. 621, https://doi.org/10.3390/ph19040621.